These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3332914)

  • 61. Randomized, double-blind trial of exifone versus cognitive problems in Parkinson's disease.
    Allain H; Denmat J; Bentue-Ferrer D; Milon D; Pignol P; Reymann JM; Pape D; Sabouraud O; Van den Driessche J
    Fundam Clin Pharmacol; 1988; 2(1):1-12. PubMed ID: 3286439
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Biopterin in Parkinson's disease.
    Moore AP; Behan PO; Jacobson W; Armarego WL
    J Neurol Neurosurg Psychiatry; 1987 Jan; 50(1):85-7. PubMed ID: 3546599
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Lecithin treatment of cognitively impaired Parkinson's patients.
    Tweedy JR; Garcia CA
    Eur J Clin Invest; 1982 Feb; 12(1):87-90. PubMed ID: 6802657
    [TBL] [Abstract][Full Text] [Related]  

  • 64. PD and ciladopa.
    Goodin DS; Aminoff MJ
    Neurology; 1988 Jan; 38(1):167. PubMed ID: 3336454
    [No Abstract]   [Full Text] [Related]  

  • 65. Recurrent oral ulceration treated with Mysteclin: a controlled study.
    Denman AM; Schiff AA
    Br Med J; 1979 May; 1(6173):1248-9. PubMed ID: 378317
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A double-blind evaluation of rigidyl in Parkinson's disease.
    Strang RR
    Acta Neurol Scand; 1966; 42(4):472-6. PubMed ID: 4380671
    [No Abstract]   [Full Text] [Related]  

  • 67. The use of choline chloride in ataxic disorders.
    Lawrence CM; Millac P; Stout GS; Ward JW
    J Neurol Neurosurg Psychiatry; 1980 May; 43(5):452-4. PubMed ID: 6999128
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Alcohol drinking reduces hand tremor.
    Landauer AA
    Br J Addict; 1981 Dec; 76(4):429-30. PubMed ID: 6947818
    [No Abstract]   [Full Text] [Related]  

  • 69. Potential of transdermal drug delivery in Parkinson's disease.
    Pfeiffer RF
    Drugs Aging; 2002; 19(8):561-70. PubMed ID: 12207550
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet in Parkinson's disease.
    Olanow CW; Fahn S; Muenter M; Klawans H; Hurtig H; Stern M; Shoulson I; Kurlan R; Grimes JD; Jankovic J
    Mov Disord; 1994 Jan; 9(1):40-7. PubMed ID: 8139604
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Parallel double-blind study of pergolide in Parkinson's disease.
    Jankovic J; Orman J
    Adv Neurol; 1987; 45():551-4. PubMed ID: 3548265
    [No Abstract]   [Full Text] [Related]  

  • 72. Controlled-release carbidopa-levodopa (Sinemet) in combination with standard Sinemet in advanced Parkinson's disease.
    Mark MH; Sage JI
    Ann Clin Lab Sci; 1989; 19(2):101-6. PubMed ID: 2665626
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Double-blind controlled study of pergolide mesylate as an adjunct to Sinemet in the treatment of Parkinson's disease.
    Olanow CW; Alberts MJ
    Adv Neurol; 1987; 45():555-60. PubMed ID: 3548266
    [No Abstract]   [Full Text] [Related]  

  • 74. A double-blind evaluation of ciladopa in Parkinson's disease.
    Weiner WJ; Factor SA; Sanchez-Ramos J; Berger J
    Mov Disord; 1987; 2(3):211-7. PubMed ID: 3332914
    [TBL] [Abstract][Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.